Capital Research Global Investors
NVRO

Capital Research Global Investors’s NEVRO CORP. NVRO Stock Holding History

Capital Research Global Investors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,582,704
Closed -$128M – 459
2021
Q4 		$128M Buy
1,582,704
+213,670
+16% +$21.4M 0.03% 297
2021
Q3 		$159M Buy
1,369,034
+302,849
+28% +$39.6M 0.04% 266
2021
Q2 		$177M Buy
1,066,185
+156,379
+17% +$24.4M 0.04% 258
2021
Q1 		$127M Buy
909,806
+110,086
+14% +$18M 0.03% 283
2020
Q4 		$138M Buy
+799,720
New +$130M 0.04% 267

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Capital Research Global Investors's NVRO Position: Q1 2022 in Review

Capital Research Global Investors sold out of NEVRO CORP. (NVRO) in Q1 2022, closing a stake of 1,582,704 shares — an estimated $128M sold.

Capital Research Global Investors first reported a position in NVRO in Q4 2020 and held it in 5 quarters. The position peaked at $177M in Q2 2021. 195 funds tracked by Wall St. Rank hold NVRO as of Q1 2022.

  • Capital Research Global Investors reported no remaining NEVRO CORP. position as of Q1 2022 after selling out during the quarter.
  • Capital Research Global Investors sold 1,582,704 NEVRO CORP. shares in Q1 2022, an estimated $128M.
  • Capital Research Global Investors first reported a position in NEVRO CORP. in Q4 2020 and held it in 5 quarters.
  • Capital Research Global Investors's NEVRO CORP. position peaked at $177M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2022.

Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.